157 related articles for article (PubMed ID: 24009274)
1. Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
Adams HJ; Kwee TC; Nievelstein RA
J Nucl Med; 2013 Nov; 54(11):2017-8. PubMed ID: 24009274
[No Abstract] [Full Text] [Related]
2. Reply: Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
Berthet L; Humbert O; Cochet A
J Nucl Med; 2013 Nov; 54(11):2018. PubMed ID: 24029654
[No Abstract] [Full Text] [Related]
3. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
5. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
7. Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.
Hong J; Lee JH
Ann Hematol; 2013 Apr; 92(4):565-6. PubMed ID: 23086509
[No Abstract] [Full Text] [Related]
8. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.
Cortés-Romera M; Sabaté-Llobera A; Mercadal-Vilchez S; Climent-Esteller F; Serrano-Maestro A; Gámez-Cenzano C; González-Barca E
Clin Nucl Med; 2014 Jan; 39(1):e46-52. PubMed ID: 23640215
[TBL] [Abstract][Full Text] [Related]
9. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH
Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868
[TBL] [Abstract][Full Text] [Related]
10. Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate.
Cheng G
Ann Hematol; 2013 Jan; 92(2):283-4. PubMed ID: 22885991
[No Abstract] [Full Text] [Related]
11. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
Adams HJ; Nievelstein RA; Kwee TC
Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144
[TBL] [Abstract][Full Text] [Related]
12. Bilateral cutaneous diffuse large B-cell lymphoma on FDG PET/CT.
Kalender E; Yilmaz M; Erkilic S; Yilmaz M; Celen Z
Clin Nucl Med; 2011 Oct; 36(10):e153-5. PubMed ID: 21892030
[No Abstract] [Full Text] [Related]
13. An unusual case of diffuse large B-cell lymphoma involving the vulva evaluated by 18F-FDG PET/CT.
Treglia G; Paone G; Perriard U; Ceriani L; Giovanella L
Clin Nucl Med; 2014 Oct; 39(10):e439-41. PubMed ID: 24152653
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Efficacy of
Guo B; Qin R; Gu ZY; Li YF; Gao L; Huang WR
Biomed Environ Sci; 2023 Jun; 36(6):510-516. PubMed ID: 37424244
[TBL] [Abstract][Full Text] [Related]
15. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
16. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
[TBL] [Abstract][Full Text] [Related]
17. Peripheral bone involvement of intravascular large B-cell lymphoma on 99mTc-MDP bone scan and 18F-FDG PET/CT.
Oh SY; Cheon GJ; Jeong E; Lee S; Park TG; Pahk K; Choe JG
Clin Nucl Med; 2012 Aug; 37(8):810-1. PubMed ID: 22785520
[TBL] [Abstract][Full Text] [Related]
18. Staging DLBCL: bone marrow biopsy or PET-CT?
Avigdor A
Blood; 2013 Jul; 122(1):4-5. PubMed ID: 23828884
[TBL] [Abstract][Full Text] [Related]
19. Current status of the role of PET imaging in diffuse large B-cell lymphoma.
Moskowitz CH; Schöder H
Semin Hematol; 2015 Apr; 52(2):138-42. PubMed ID: 25805593
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT demonstrating primary bone lymphoma of the extremities mimicking an inflammatory peripheral arthropathy.
Tachibana A; Robinson RJ; Patel CN
Clin Nucl Med; 2015 Feb; 40(2):169-71. PubMed ID: 25140543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
